会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • 2,3,4-substituted cyclopentanones as therapeutic agents
    • 2,3,4-取代环戊酮作为治疗剂
    • US07101906B2
    • 2006-09-05
    • US10991284
    • 2004-11-16
    • Yariv DondeRobert M. BurkMichael E. GarstJeremiah H. Nguyen
    • Yariv DondeRobert M. BurkMichael E. GarstJeremiah H. Nguyen
    • A61K31/881C07D333/56C07D333/62
    • C07D333/62C07C405/0025C07D333/56
    • Disclosed herein are compounds comprising or a pharmaceutically acceptable salt or a prodrug thereof, wherein a dashed line represents the presence or absence of a bond; Y is a carboxylic acid, sulfonic acid, or phosphonic acid functional group; or an amide or ester thereof comprising from 0 to 12 carbon atoms; or Y is hydroxymethyl or an ether thereof comprising from 0 to 12 carbon atoms; or Y is a tetrazolyl functional group; A is —(CH2)6—, cis —CH2—CH═CH—(CH2)3—, or —CH2—C≡C—(CH2)3— wherein 1 or 2 carbons may be substituted with S or O; B is hydrogen, C1-6 hydrocarbyl, CN, CO2H, or —(CH2)mX(CH2)pH, wherein m is at least 1 and the sum of m and p is from 1 to 5; X is S or O; J is H, CH3, or CF3; D is a covalent bond, CH2, O, or S; and E is an aromatic heterobicyclic ring system which may have substituents comprising up to 6 non-hydrogen atoms each. Methods, compositions, and medicaments related thereto are also disclosed.
    • 本文公开了包含其药学上可接受的盐或其前药的化合物,其中虚线表示存在或不存在键; Y是羧酸,磺酸或膦酸官能团; 或其包含0至12个碳原子的酰胺或酯; 或Y是含有0至12个碳原子的羟甲基或其醚; 或Y为四唑基官能团; A是 - (CH 2 CH 2)6 - ,顺式-CH 2 -CH-CH-(CH 2 CH 2) )3 - 或 - CH 2-C≡C-(CH 2)3 - 其中1或 2个碳可以被S或O取代; B是氢,C 1-6烃基,CN,CO 2 H或 - (CH 2 CH 2)m H 其中m至少为1,m和p之和为1至5; X是S或O; J是H,CH 3或CF 3; D是共价键,CH 2,O或S; 并且E是芳族杂双环系统,其可以具有各自包含多达6个非氢原子的取代基。 还公开了与之相关的方法,组合物和药物。